

Coca-Cola Europacific Partners vs Kimberly-Clark
Major bottler of Coca-Cola drinks across Europe and Asia vs Global maker of household and personal care products. Which is the better buy for your portfolio in November 2026? Plain-English answer below.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kleenex, Huggies, and Scott paper products to households around the world. Coca-Cola Europacific Partners vs Kimberly-Clark both generate predictable cash flows from consumer staples brands with deep shelf-space dominance, making them favorites for dividend investors. The analysis examines organic revenue growth, volume trends, cost pass-through ability, and which company delivers stronger earnings per share growth.
Coca-Cola Europacific Partners bottles and distributes Coke products across Western Europe and Australia under a long-term franchise agreement with the Coca-Cola Company, while Kimberly-Clark sells Kl...
Why It’s Moving

CCEP Resilience Tested: Cost Pressures Offset Strong Q3 Volume Growth
- Revenue grew 5.8% on a comparable, foreign-exchange-neutral basis, supported by a 3.6% increase in volume and higher revenue per unit case.
- CEO Damian Gammell highlighted balanced performance across regions, channels, and product categories, signaling operational stability despite macro headwinds.
- Management flagged emerging cost pressures from geopolitical tensions but emphasized resilience through tight spending controls and productivity gains.

Kimberly-Clark Beats Earnings Estimates as Kenvue Integration and Cost Synergies Drive Profit Growth
- Q3 net income rose sharply, beating estimates primarily due to lower interest costs, even though organic sales declined amid pricing pressures and false quality claims affecting diaper sales in China.
- The company officially completed the acquisition of Kenvue, creating a global consumer health leader with 10 billion-dollar brands and reiterating targets for approximately $2.1 billion in run-rate synergies.
- Management maintained its full-year adjusted EPS guidance, signaling confidence in the integration pipeline and defensive cash generation capabilities despite softer top-line performance.

CCEP Resilience Tested: Cost Pressures Offset Strong Q3 Volume Growth
- Revenue grew 5.8% on a comparable, foreign-exchange-neutral basis, supported by a 3.6% increase in volume and higher revenue per unit case.
- CEO Damian Gammell highlighted balanced performance across regions, channels, and product categories, signaling operational stability despite macro headwinds.
- Management flagged emerging cost pressures from geopolitical tensions but emphasized resilience through tight spending controls and productivity gains.

Kimberly-Clark Beats Earnings Estimates as Kenvue Integration and Cost Synergies Drive Profit Growth
- Q3 net income rose sharply, beating estimates primarily due to lower interest costs, even though organic sales declined amid pricing pressures and false quality claims affecting diaper sales in China.
- The company officially completed the acquisition of Kenvue, creating a global consumer health leader with 10 billion-dollar brands and reiterating targets for approximately $2.1 billion in run-rate synergies.
- Management maintained its full-year adjusted EPS guidance, signaling confidence in the integration pipeline and defensive cash generation capabilities despite softer top-line performance.
Investment Analysis
Pros
- Reported solid Q3 2025 revenue growth of 1.0%, driven by volume growth and higher revenue per unit case.
- Continues to increase market share ahead of competition within its territories.
- Receives mostly positive analyst sentiment, with an average price target indicating upside potential near 9-19%.
Considerations
- Modest volume growth at only 0.4% in Q3 suggests limited near-term expansion in core beverage sales.
- Analyst opinions are mixed, with some Hold and Sell ratings alongside Buy recommendations, reflecting some uncertainty.
- Short selling activity remains notable at 8.88%, indicating some investor bearishness or hedging.
Pros
- Kimberly-Clark's price-to-earnings ratio of 16.27 is below its 3-, 5-, and 10-year averages, potentially indicating value relative to its history.
- Market capitalization around $31 billion reflects its status as a leading global consumer goods company.
- Maintains steady financial metrics amid competitive pressure in personal care and household products.
Considerations
- Current PE ratio below historical averages may partly reflect slower growth or margin pressure concerns.
- Faces industry-wide challenges including inflationary cost pressures and evolving consumer preferences.
- Competitive dynamics could impact pricing power and margin sustainability in key product categories.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next scheduled earnings-related update is November 3, 2026. It is expected to cover the company’s third quarter of fiscal 2026. The release is likely to be a Q3 trading update rather than a full quarterly earnings report, consistent with CCEP’s reporting pattern.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark Corporation has a confirmed upcoming earnings date scheduled for November 5, 2026. This report will cover the company's third-quarter fiscal results. The specific time of day for this release is currently listed as To Be Determined.
Coca-Cola Europacific Partners (CCEP) Next Earnings Date
CCEP’s next scheduled earnings-related update is November 3, 2026. It is expected to cover the company’s third quarter of fiscal 2026. The release is likely to be a Q3 trading update rather than a full quarterly earnings report, consistent with CCEP’s reporting pattern.
Kimberly-Clark (KMB) Next Earnings Date
Kimberly-Clark Corporation has a confirmed upcoming earnings date scheduled for November 5, 2026. This report will cover the company's third-quarter fiscal results. The specific time of day for this release is currently listed as To Be Determined.
Buy CCEP or KMB in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


